Unearthing a source of medicinal molecules

Drug Discovery Today

Volumn 15, Issue 21-22, 2010, Pages 966-972

  Cooper, Edwin L ^a   Balamurugan, M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; BOLUOKE; EARTHWORM EXTRACT; INDOMETACIN; LUMBROKINASE; PARACETAMOL; PHERETIMA EXTRACT; PLANT EXTRACT; PLASMINOGEN ACTIVATOR; RANITIDINE; UNCLASSIFIED DRUG;

BREATHING DISORDER; CHINESE MEDICINE; CLINICAL TRIAL; COUGHING; DRUG ACTIVITY; DRUG MECHANISM; EARTHWORM; HUMAN; IC 50; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER PROTECTION; LIVER STRUCTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW;

ANIMALS; BLOOD COAGULATION DISORDERS; DRUG DISCOVERY; ENDOPEPTIDASES; HUMANS; IMMUNITY, HUMORAL; MEDICINE, AYURVEDIC; MEDICINE, CHINESE TRADITIONAL; OLIGOCHAETA;

EID: 78349310177     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.09.004     Document Type: Review

References (69)

1. Cooper E.L. From Darwin and Metchnikoff to Burnet and beyond. Trends in Innate Immunity 2008, 1-11. Karger. L.A. Egesten, L.H. Herwald, W.A. Schmidt (Eds.).
2. Cooper E.L. Drug discovery, CAM and natural products. Evid. Based Complement. Alternat. Med. 2004, 1:215-217.
3. Cooper E.L. CAM, eCAM, bioprospecting: the 21st century pyramid. Evid. Based Complement. Alternat. Med. 2005, 2:125-127.
4. Cooper E.L. Bioprospecting: a CAM frontier. Evid. Based Complement. Alternat. Med. 2005, 2:1-3.
5. Engelmann P., et al. Comparative analyses of earthworm immune system using cell surface and intracellular markets. A New Model for Analyzing Antimicrobial Peptides with Biomedical Applications 2002, 53-57. IOS Press. E.L. Cooper (Ed.).
6. Cooper E.L. The earthworm: a new model with biomedical applications. A New Model for Analyzing Antimicrobial Peptides with Biomedical Applications 2002, 3-28. IOS Press. E.L. Cooper (Ed.).
7. Cooper E.L. New enzyme complex isolated from earthworms is potent fibrinolytic: lumbrokinase has anti-platelet, anti-thrombotic activity. Focus: Allergy Research Group Newsletter March 2009, 2-5.
8. Wei W. Forecast of research on anti-cancer effects of Di Long capsules. Chin. J. Clin. Res. Tumor 1991, 18:131-132.
9. Cheng N.N., et al. Di Long phospholipid structure and platelet activating factor synthesis. J. Pharm. 1992, 27:886.
10. Li W., et al. Using HPLC to determine quantity of hypoxanthine, xanthine, uracil, and uridyl in Di Long. J. Tradit. Chin. Med. Mater. 1996, 19:625-627.
11. Chen B.Y, et al. Analgesic and antipyretic effects of Di Long powder in mice, rats and rabbits. J. Shanghai Med. Univ. 1996, 23:225-226.
12. Zhang F.X., et al. Experimental research on products from earthworm's body that kills sperms. Shaanxi J. TCM 1996, 17:234-236.
13. Chen, J.B. et al. (1997) Chemical composition analysis of Di Long. Journal of Chinese Patented Medicine 19, 35-36.
14. Zhang F.C., et al. Di Long's enhancing effect on macrophages' immune activity. Chin. J. Pharm. 1998, 33:532-535.
15. Wang G.Z., et al. Chemical composition analysis of Di Long related herbal material. J. Tradit. Chin. Med. Mater. 1998, 21:133-135.
16. Cooper E.L., et al. Earthworms: sources of antimicrobial and anticancer molecules. Complementary and Alternative Approaches to Biomedicine 2004, 359-390. Kluwer Academic/Plenum Publishers. E.L. Cooper, N. Yamaguchi (Eds.).
17. Balamurugan M., et al. Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties. J. Zhejiang Univ. Sci. B 2008, 9:141-147.
18. Ranganathan, L.S. (2006) Vermibiotechnology-from Soil Health to Human Health, Agrobios.
19. Ismail S.A., et al. Anti-inflammatory activity of earthworm extracts. Soil Biol. Biochem. 1992, 24:1253-1254.
20. Prakash M., Ranganathan L.S. Anti-ulceral and anti-oxidative properties of "earthworm paste" of Lampito mauritii (Kinberg) on Rattus norvegicus. Eur. Rev. Med. Pharmacol. Sci. 2007, 11:9-15.
21. Balamurugan M. Earthworm paste (Lampito mauritii, Kinberg) alters inflammatory, oxidative, haematological and serum biochemical indices of inflamed rat. Eur. Rev. Med. Pharmacol. Sci. 2007, 11:77-90.
22. Balamurugan M. Anti-inflammatory and antipyretic activities of earthworm extract- Lampito mauritii. J. Ethnopharmacol. 2009, 121:330-332.
23. Prakash M. Effect of earthworm powder on antioxidant enzymes in alcohol induced hepatotoxic rats. Eur. Rev. Med. Pharmacol. Sci. 2008, 12:237-243.
24. Cho J.H., et al. Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization. Biochim. Biophys. Acta 1998, 1408:67-76.
25. Dong G.Q., et al. Molecular cloning and characterization of cDNA encoding fibrinolytic enzyme-3 from earthworm Eisenia foetida. Acta Biochim. Biophys. Sin. (Shanghai) 2004, 36:303-308.
26. Zhao J., et al. Earthworm fibrinolytic enzyme. Stud. Nat. Prod. Chem. 2005, 30:825-847.
27. Ge T., et al. Cloning of thrombolytic enzyme (lumbrokinase) from earthworm and its expression in the yeast Pichia pastoris. Protein Expr. Purif. 2005, 42:20-28.
28. Hu Y., et al. Cloning and expression of earthworm fibrinolytic enzyme PM246 in Pichia pastoris. Protein Expr. Purif. 2005, 43:18-25.
29. Cheng M.B., et al. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. J. Control. Release 2008, 129:41-48.
30. Hahn B.S., et al. Evaluation of the in vivo antithrombotic, antocoagulant, and fibrinolytic activities of Lumbricus rubellus earthworm powder. Arch. Pharm. Res. 1997, 20:17-23.
31. Kim Y.S., et al. Dose dependency of earthworm powder on antithrombotic and fibrinolytic effects. Arch. Pharm. Res. 1998, 21:374-377.
32. Mihara H., et al. A novel fribrinolytic enzyme extracted from the earthworm, Lumbricus rubellus. Jpn. J. Physiol. 1991, 41:461-472.
33. Jin L., et al. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase. Clin. Hemorheol. Microcirc. 2000, 23:213-218.
34. Ge T., et al. High density fermentation and activity of a recombinant lumbrokinase (PI239) from Pichia pastoris. Protein Expr. Purif. 2007, 52:1-7.
35. Yamaji A., et al. Lysenin, a novel sphingomyelin-specific binding protein. J. Biol. Chem. 1998, 273:5300-5306.
36. Kobayashi H., et al. Biology of lysenin, a protein in the coelomic fluid of the earthworm Eisenia foetida. Int. Rev. Cytol. 2004, 236:45-99.
37. Chu X., et al. In vitro and in vivo evaluation of the anti-asthmatic activities of fractions from Pheretima. J. Ethnopharmacol. 2007, 111:490-495.
38. Wallace R.W. Drugs from the sea: harvesting the results of aeons of chemical evolution. Mol. Med. Today 1997, 3:291-295.
39. Haefner B. Drugs from the deep: marine natural products as drug candidates. Drug Discov. Today 2003, 8:536-544.
40. Cooper E.L. eCAM: an emerging linkage with ethnopharmacology?. Evid. Based Complement. Alternat. Med. 2008, 5:365-366.
41. Wang F., et al. Purification, characterization and crystallization of a group of earthworm fibrinolytic enzymes from Eisenia fetida. Biotechnol. Lett. 2003, 25:1105-1109.
42. Cho I.H., et al. Purification and characterization of six fibrinolytic serine-proteases from earthworm Lumbricus rubellus. J. Biochem. Mol. Biol. 2004, 37:199-205.
43. Tang Y., et al. Crystal structure of earthworm fibrinolytic enzyme component A: revealing the structural determinants of its dual fibrinolytic activity. J. Mol. Biol. 2002, 321:57-68.
44. Hrzenjak T.M., et al. Fibrinolytic activity of earthworms extract (G-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors. Pathol. Oncol. Res. 1998, 4:201-211.
45. Hu W., Fu T. Isolation and properties of a novel fibrinolytic enzyme from an earthworm. Zhong Yao Cai 1997, 20:78-81.
46. Zhao J., et al. Hydrolysis of fibrinogen and plasminogen by immobilized earthworm fibrinolytic enzyme II from Eisenia fetida. Int. J. Biol. Macromol. 2003, 32:165-171.
47. Liu X.H., Ge F. Factors influencing the activity of fibrinolytic enzymes from earthworm, Eisenia foetida. Zhongguo Zhong Yao Za Zhi 2002, 27:423-426.
48. Mihara H., et al. A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus. Jpn. J. Physiol. 1991, 41:461-472.
49. Nakajima A., et al. Specific clonal T cell accumulation in intestinal lesions of Crohn's disease. J. Immunol. 1996, 157:5683-5688.
50. Sugimoto M., Nakajima N. Molecular cloning, sequencing, and expression of cDNA encoding serine protease with fibrinolytic activity from earthworm. Biosci. Biotechnol. Biochem. 2001, 65:1575-1580.
51. Xing B.D., et al. Purification and characterization of the fibrinolytic enzyme (eFE-D) from earthworm Eisenia fetida. Acta Biochim. Biophys. Sin. (Shanghai) 1997, 29:609-612.
52. Yang J.S., Ru B.G. Purification and characterization of an SDS-activated fibrinolytic enzyme from Eisenia fetida. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1997, 118:623-631.
53. Zhao X.Y., et al. A component of earthworm fibrinolytic enzyme having higher thrombolytic activity than total components in vivo. Yao Xue Xue Bao 2006, 41:1068-1073.
54. Olivares Fontt E., et al. Trypanosoma cruzi is lysed by coelomic cytolytic factor-1, an invertebrate analogue of TNF, and induces phenoloxidase activity in the coelomic fluid of Eisenia foetida. Dev. Comp. Immunol. 2002, 26:27-34.
55. Hrzenjak T., et al. New source of active compounds- earthworm tissue (Eisenia fetida, Lumbricus rubellus). Comp. Biochem. Physiol. 1992, 102:441-447.
56. Kauschke E., Mohrig W. Comparative analysis of hemolytic and hemagglutinating activities in the coelomic fluid of Eisenia foetida and Lumbricus terrestris (Annelida, Lumbricidae). Dev. Comp. Immunol. 1987, 11:331-341.
57. Kauschke E., et al. Evidence for perforin-like activity associated with earthworm leukocytes. Zoology (Jena) 2001, 104:13-24.
58. Kobayashi H., et al. Biology of lysenin, a protein in the coelomic fluid of the earthworm Eisenia fetida. Int. Rev. Cytol. 2004, 236:45-99.
59. Lange S., et al. Biochemical characteristics of Eiseniapore, a pore-forming protein in the coelomic fluid of earthworms. Eur. J. Biochem. 1999, 262:547-556.
60. Milochau A., et al. Purification, characterization and activities of two hemolytic and antibacterial proteins from coelomic fluid of the annelid Eisenia fetida andrei. Biochim. Biophys. Acta 1997, 1337:123-132.
61. Mohrig W., et al. Crossreactivity of hemolytic and hemagglutinating proteins in the coelomic fluid of lumbricidae (Annelida). Comp. Biochem. Physiol. Physiol. 1996, 116A:19-30.
62. Roch P., et al. Protein analysis of earthworm coelomic fluid. II. Isolation and biochemical characterization of the Eisenia fetida andrei factor (EFAF). Comp. Biochem. Physiol. 1981, 69B:829-836.
63. Roch Ph., et al. Interactions between earthworm hemolysins and sheep red blood cell membranes. Biochim. Biophys. Acta 1989, 983:193-198.
64. Sekizawa Y., et al. Molecular cloning of cDNA for lysenin, a novel protein in the earthworm, Eisenia foetida that causes contraction of rat vascular smooth muscle. Gene 1997, 191:97-102.
65. Lassegues M., et al. Sequence and expression of an Eisenia foetida derived cDNA clone that encodes the 40kD fetidin antibacterial protein. Eur. J. Biochem. 1997, 246:756-762.
66. Beschin A., et al. Identification and cloning of a glucan- and lipopolysaccharide-binding protein from Eisenia foetida earthworm involved in the activation of prophenoloxidase cascade. J. Biol. Chem. 1998, 273:24948-24954.
67. Cho J.H., et al. Lumbricin I a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization. Biochim. Biophys. Acta 1998, 1408:67-76.
68. Balamurugan M. Restoration of histoarchitecture in the paracetamol-induced liver damaged rat by earthworm extract, Lampito mauritii. Eur. Rev. Med. Pharmacol. Sci. 2007, 11:407-411.
69. Cooper E.L., et al. Digging for innate immunity since Darwin and Metchnikoff. Bioessays 2002, 24:319-333.